StockCIK 1281895
ROCKET PHARMACEUTICALS, INC. (RCKT): Insider Trades and Fund Holdings
In the past 12 months, ROCKET PHARMACEUTICALS, INC. insiders reported 0 open-market purchases worth $0 and 7 sales worth $432K; 0 of the sales were reported as made under a 10b5-1 trading plan.
0Insider buys, 12 months
$0Bought by insiders, 12 months
$432KSold by insiders, 12 months
1Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 15, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Sep 15 | Martin WilsonGeneral Counsel | ▼ SELL | $256K |
| Aug 20 | Gaurav ShahCEO | ▼ SELL | $8K |
| Aug 20 | Martin WilsonGeneral Counsel | ▼ SELL | $2K |
| Aug 17 | Martin WilsonGeneral Counsel | ▼ SELL | $12K |
| Aug 17 | Gaurav ShahCEO | ▼ SELL | $10K |
| Aug 13 | Christopher James StevensCOO | ▼ SELL | $128K |
| Aug 13 | Sarbani ChaudhuriSee Remarks | ▼ SELL | $16K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Martin Wilson | General Counsel | 0 | $0 | 3 | $270K |
| Gaurav Shah | CEO | 0 | $0 | 2 | $17K |
| Christopher James Stevens | COO | 0 | $0 | 1 | $128K |
| Sarbani Chaudhuri | See Remarks | 0 | $0 | 1 | $16K |
ADVERTISEMENT
320 × 100 ad slot
Tracked funds that report RCKT
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 792,974 | $2.71M | ▲ +24.5% |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →